Bio-rad Laboratories, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Bio-Rad Laboratories, Inc. issues its 2026 proxy statement, seeking approval for director elections, auditor ratification, executive compensation, and an expanded equity incentive plan, while facing a shareholder proposal to eliminate its dual-class stock structure.
NYSE
Bio-Rad Laboratories will hold its annual stockholders meeting on April 22, 2025, to vote on director elections, auditor ratification, and an executive severance proposal.
NYSE
Bio-Rad Laboratories is set to hold its annual stockholder meeting on April 23, 2024, to vote on director elections, auditor ratification, and approval of an amended incentive award plan.